Terms: = Kidney tumors AND MYCN, N-myc, 4613, ENSG00000134323, NMYC, MODED, ODED AND Prognosis
25 results:
1. Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract] [Full Text] [Related]
2. A Novel Inflammation-Related Gene Signature for Overall Survival Prediction and Comprehensive Analysis in Pediatric Patients with Wilms Tumor.
Zhang J; Lai Y; Zhu L; Lu Z; Hu C; Zhou H; Lu Z; Tang Z; He Z; Tang F
Dis Markers; 2022; 2022():2651105. PubMed ID: 35578692
[TBL] [Abstract] [Full Text] [Related]
3. Bromodomain 4 inhibition leads to mycn downregulation in Wilms tumor.
Woods AD; Berlow NE; Ortiz MV; Dela Cruz F; Siddiquee A; Coutinho DF; Purohit R; Freier KET; Michalek JE; Lathara M; Matlock K; Srivivasa G; Royer-Pokora B; Veselska R; Kung AL; Keller C
Pediatr Blood Cancer; 2022 Feb; 69(2):e29401. PubMed ID: 34693628
[TBL] [Abstract] [Full Text] [Related]
4. A highly malignant case of neuroblastoma with substantial increase of single-nucleotide variants and normal mismatch repair system: A case report.
Yuan LQ; Wang JH; Zhu K; Yang M; Gu WZ; Lai C; Li HM; Shu Q; Chen X
Medicine (Baltimore); 2017 Dec; 96(50):e8845. PubMed ID: 29390274
[TBL] [Abstract] [Full Text] [Related]
5. Multiple mechanisms of mycn dysregulation in Wilms tumour.
Williams RD; Chagtai T; Alcaide-German M; Apps J; Wegert J; Popov S; Vujanic G; van Tinteren H; van den Heuvel-Eibrink MM; Kool M; de Kraker J; Gisselsson D; Graf N; Gessler M; Pritchard-Jones K
Oncotarget; 2015 Mar; 6(9):7232-43. PubMed ID: 25749049
[TBL] [Abstract] [Full Text] [Related]
6. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.
Wegert J; Ishaque N; Vardapour R; Geörg C; Gu Z; Bieg M; Ziegler B; Bausenwein S; Nourkami N; Ludwig N; Keller A; Grimm C; Kneitz S; Williams RD; Chagtai T; Pritchard-Jones K; van Sluis P; Volckmann R; Koster J; Versteeg R; Acha T; O'Sullivan MJ; Bode PK; Niggli F; Tytgat GA; van Tinteren H; van den Heuvel-Eibrink MM; Meese E; Vokuhl C; Leuschner I; Graf N; Eils R; Pfister SM; Kool M; Gessler M
Cancer Cell; 2015 Feb; 27(2):298-311. PubMed ID: 25670083
[TBL] [Abstract] [Full Text] [Related]
7. Proteomics identified nuclear n-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract] [Full Text] [Related]
8. Primary renal neuroblastoma--a clinical pathologic study of 8 cases.
Fan R
Am J Surg Pathol; 2012 Jan; 36(1):94-100. PubMed ID: 21989352
[TBL] [Abstract] [Full Text] [Related]
9. High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastoma.
Sartelet H; Ohta S; Barrette S; Rougemont AL; Brevet M; Regairaz M; Harvey I; Bernard C; Fabre M; Gaboury L; Oligny LL; Bosq J; Valteau-Couanet D; Vassal G
Histopathology; 2010 Apr; 56(5):607-16. PubMed ID: 20459571
[TBL] [Abstract] [Full Text] [Related]
10. [Neonatal neuroblastoma and prenatal diagnosis].
Messina M; Di Maggio G; Garzi A; Molinaro F; Amato G; Ferrara F
Minerva Pediatr; 2009 Jun; 61(3):349-54. PubMed ID: 19461577
[TBL] [Abstract] [Full Text] [Related]
11. Fine needle biopsy and genetics, two allied weapons in the diagnosis, prognosis, and target therapeutics of solid pediatric tumors.
Barroca H
Diagn Cytopathol; 2008 Sep; 36(9):678-84. PubMed ID: 18677757
[TBL] [Abstract] [Full Text] [Related]
12. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
[TBL] [Abstract] [Full Text] [Related]
13. Neuroblastoma preoperatively treated as nephroblastoma: does inadequate therapy worsen the prognosis?
Hero B; Graf N; Simon T; Weirich A; Tröger J; Berthold F
Klin Padiatr; 2002; 214(4):157-61. PubMed ID: 12165895
[TBL] [Abstract] [Full Text] [Related]
14. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour.
Baudry D; Faussillon M; Cabanis MO; Rigolet M; Zucker JM; Patte C; Sarnacki S; Boccon-Gibod L; Junien C; Jeanpierre C
Oncogene; 2002 Aug; 21(36):5566-73. PubMed ID: 12165855
[TBL] [Abstract] [Full Text] [Related]
15. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
Azuhata T; Scott D; Takamizawa S; Wen J; Davidoff A; Fukuzawa M; Sandler A
J Pediatr Surg; 2001 Dec; 36(12):1785-91. PubMed ID: 11733907
[TBL] [Abstract] [Full Text] [Related]
16. Expression of glypican 3 (GPC3) in embryonal tumors.
Saikali Z; Sinnett D
Int J Cancer; 2000 Sep; 89(5):418-22. PubMed ID: 11008203
[TBL] [Abstract] [Full Text] [Related]
17. Risk-based management: current concepts of treating malignant solid tumors of childhood.
Grosfeld JL
J Am Coll Surg; 1999 Oct; 189(4):407-25. PubMed ID: 10509467
[TBL] [Abstract] [Full Text] [Related]
18. New entities, concepts, and questions in childhood tumor pathology.
Harms D
Gen Diagn Pathol; 1995 May; 141(1):1-14. PubMed ID: 8542501
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistology, cytogenetics, and molecular studies of small round cell tumors of childhood. A review.
Winters JL; Geil JD; O'Connor WN
Ann Clin Lab Sci; 1995; 25(1):66-78. PubMed ID: 7762971
[TBL] [Abstract] [Full Text] [Related]
20. Are CD44 variant isoforms involved in human tumour progression?
Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
[TBL] [Abstract] [Full Text] [Related]
[Next]